help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-1249
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/7/2712    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takebayashi, K.
Right arrow Articles by Inukai, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takebayashi, K.
Right arrow Articles by Inukai, T.
Related Collections
Right arrow Diabetes and Insulin
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 7 2712-2719
Copyright © 2007 by The Endocrine Society

Retinol Binding Protein-4 Levels and Clinical Features of Type 2 Diabetes Patients

Kohzo Takebayashi, Mariko Suetsugu, Sadao Wakabayashi, Yoshimasa Aso and Toshihiko Inukai

Department of Internal Medicine, Dokkyo Medical University Koshigaya Hospital, Koshigaya 343-8555, Japan

Address all correspondence and requests for reprints to: Kohzo Takebayashi, M.D., Department of Internal Medicine, Dokkyo Medical University Koshigaya Hospital, 2-1-50, Minami-Koshigaya, Koshigaya 343-8555, Japan. E-mail: takeb{at}gmail.plala.or.jp.

Context: Retinol binding protein (RBP)-4 is a recently identified adipocytokine that is associated with insulin resistance.

Objectives: The aim was to investigate the association between RBP4 and various markers related to insulin resistance and diabetic complications in type 2 diabetic patients. The effect on RBP4 of the addition of pioglitazone to other diabetic medications was also examined.

Design, Setting, Patients, Intervention, and Main Outcome Measures: RBP4 levels were measured in 101 hospitalized patients with type 2 diabetes and in 22 nonhospitalized control subjects. Endothelial function was evaluated using flow-mediated vasodilatation. In a further 22 nonhospitalized type 2 diabetic patients, pioglitazone (30 mg/d) was administered for 12 wk while other medications for diabetes were continued.

Results: There was a significant elevation of RBP4 levels in diabetic patients compared with healthy subjects. RBP4 showed significant positive correlations with triglyceride, systolic blood pressure, and log urinary albumin excretion, and significant negative correlations with high-density lipoprotein cholesterol and flow-mediated vasodilatation. In stepwise regression analysis, log urinary albumin excretion, triglyceride, and gender showed a significant association with RBP4. RBP4 was significantly elevated in patients with proliferative-diabetic retinopathy compared with nondiabetic retinopathy and simple-diabetic retinopathy patients. The addition of pioglitazone for 12 wk to other diabetic medications the patients were already taking did not affect the serum RBP4 concentration.

Conclusions: The current study shows that RBP4 is associated with variables related to insulin resistance and diabetic complications. The addition of pioglitazone for 12 wk to other diabetic medications the patients were already taking did not affect serum RBP4 levels.




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
J. P. Mills, H. C. Furr, and S. A. Tanumihardjo
Retinol to Retinol-Binding Protein (RBP) Is Low in Obese Adults due to Elevated apo-RBP
Experimental Biology and Medicine, October 1, 2008; 233(10): 1255 - 1261.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. H. Choi, S. H. Kwak, B.-S. Youn, S. Lim, Y. J. Park, H. Lee, N. Lee, Y. M. Cho, H. K. Lee, Y.-B. Kim, et al.
High Plasma Retinol Binding Protein-4 and Low Plasma Adiponectin Concentrations Are Associated with Severity of Glucose Intolerance in Women with Previous Gestational Diabetes Mellitus
J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3142 - 3148.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Lim, S. H. Choi, I.-K. Jeong, J. H. Kim, M. K. Moon, K. S. Park, H. K. Lee, Y.-B. Kim, and H. C. Jang
Insulin-Sensitizing Effects of Exercise on Adiponectin and Retinol-Binding Protein-4 Concentrations in Young and Middle-Aged Women
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2263 - 2268.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. Mody, T. E. Graham, Y. Tsuji, Q. Yang, and B. B. Kahn
Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice
Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E785 - E793.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Q. Qi, Z. Yu, X. Ye, F. Zhao, P. Huang, F. B. Hu, O. H. Franco, J. Wang, H. Li, Y. Liu, et al.
Elevated Retinol-Binding Protein 4 Levels Are Associated with Metabolic Syndrome in Chinese People
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4827 - 4834.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Ziegelmeier, A. Bachmann, J. Seeger, U. Lossner, J. Kratzsch, M. Bluher, M. Stumvoll, and M. Fasshauer
Serum Levels of Adipokine Retinol-Binding Protein-4 in Relation to Renal Function
Diabetes Care, October 1, 2007; 30(10): 2588 - 2592.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society